# Ultragenyx (RARE) — News

RARE · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/rare/news

## Recent headlines

- [Ultragenyx shares rise 2.1% premarket after $203 million sale of priority review voucher for rare pediatric disease](https://www.ainvest.com/news/ultragenyx-shares-rise-2-1-premarket-203-million-sale-priority-review-voucher-rare-pediatric-disease-2610) — AInvest Wire, Oct 14, 2026
  Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) shares rose 2.1% in premarket trading on October 14, 2026, following the announcement that the company had agreed to sell a Rare Pediatric Disease Priority Review Voucher for $210 million. The voucher was awarded by the U.S. Food and Drug Administration…
- [Ultragenyx to sell rare pediatric disease prv for $203M](https://www.ainvest.com/news/ultragenyx-sell-rare-pediatric-disease-prv-203m-2610) — AInvest Wire, Oct 14, 2026
- [Ultragenyx enters into agreement to sell rare pediatric disease priority review voucher for $203 million](https://www.ainvest.com/news/ultragenyx-enters-agreement-sell-rare-pediatric-disease-priority-review-voucher-203-million-2610) — AInvest Wire, Oct 14, 2026
- [Ultragenyx Pharmaceutical - Under deal with U.S. Department of Health Co to pay 20% of PRV sale proceeds to NIH - SEC filing](https://www.ainvest.com/news/ultragenyx-pharmaceutical-deal-department-health-pay-20-prv-sale-proceeds-nih-sec-filing-2610) — AInvest Wire, Oct 7, 2026
- [Ultragenyx to sell rare pediatric disease prv for $210M](https://www.ainvest.com/news/ultragenyx-sell-rare-pediatric-disease-prv-210m-2610) — AInvest Wire, Oct 7, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).